Clinical Trial Update: CARv3-TEAM-E T Cells in Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating CARv3-TEAM-E T cells for glioblastoma and malignant glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma
• Malignant Glioma

Drugs mentioned

• CARv3-TEAM-E T Cells

Snippet

Sponsor: Marcela V. Maus, M.D.,Ph.D. | Conditions: Glioblastoma, Malignant Glioma | Phase 1 | Status: RECRUITING